A Bivalent Radiopharmaceutical Targeting PSMA and Hypoxia for Improved Theranostics in Prostate Cancer – Medicine Innovates

A Bivalent Radiopharmaceutical Targeting PSMA and Hypoxia for Improved Theranostics in Prostate Cancer - Medicine Innovates